Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Shpall

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Journal of Hematotherapy|August 1, 1997
Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of DirectorsE J Shpall
Bone Marrow Transplantation|May 21, 1999
The utilization of cytokines in stem cell mobilization strategiesE J Shpall
Cancer Treatment and Research|August 19, 2000
High-dose chemotherapy for breast cancerY Nieto, E J Shpall
Hematology/Oncology Clinics of North America|November 30, 1999
Autologous stem-cell transplantation for solid tumors in adultsY Nieto, E J Shpall
Drugs|February 1, 1992
Treatment of breast cancer in the 1990s. What does the future hold?R B Jones, E J Shpall
Journal of Hematotherapy|January 1, 1994
Dissemination and commercialization of hematopoietic progenitor cell transplantationR B Jones, E J Shpall
Comprehensive Therapy|August 1, 1986
Update on understanding the causes of cancerE J Shpall, J F Holland
Medical Oncology (Northwood, London, England)|January 1, 1994
The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cellsM H Purdy, E J Shpall
Blood|February 1, 1994
Release of tumor cells from bone marrowE J Shpall, R B Jones
Blood Reviews|March 1, 1996
Mobilization and selection of CD34-positive hematopoietic progenitorsP J Cagnoni, E J Shpall
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Journal of Hematotherapy|August 1, 1997
Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of DirectorsE J Shpall
Bone Marrow Transplantation|May 21, 1999
The utilization of cytokines in stem cell mobilization strategiesE J Shpall
Cancer Treatment and Research|August 19, 2000
High-dose chemotherapy for breast cancerY Nieto, E J Shpall
Hematology/Oncology Clinics of North America|November 30, 1999
Autologous stem-cell transplantation for solid tumors in adultsY Nieto, E J Shpall
Drugs|February 1, 1992
Treatment of breast cancer in the 1990s. What does the future hold?R B Jones, E J Shpall
Journal of Hematotherapy|January 1, 1994
Dissemination and commercialization of hematopoietic progenitor cell transplantationR B Jones, E J Shpall
Comprehensive Therapy|August 1, 1986
Update on understanding the causes of cancerE J Shpall, J F Holland
Medical Oncology (Northwood, London, England)|January 1, 1994
The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cellsM H Purdy, E J Shpall
Blood|February 1, 1994
Release of tumor cells from bone marrowE J Shpall, R B Jones
Blood Reviews|March 1, 1996
Mobilization and selection of CD34-positive hematopoietic progenitorsP J Cagnoni, E J Shpall
Pageof 15